Freedom Investment Management’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-10,026
| Closed | – | – | 1194 |
|
|
2017
Q2 | $0 | Sell |
10,026
-916
| -8% | – | ﹤0.01% | 1167 |
|
|
2017
Q1 | $0 | Sell |
10,942
-296
| -3% | – | ﹤0.01% | 1141 |
|
|
2016
Q4 | $0 | Sell |
11,238
-412
| -4% | – | ﹤0.01% | 1100 |
|
|
2016
Q3 | $0 | Sell |
11,650
-441
| -4% | – | ﹤0.01% | 982 |
|
|
2016
Q2 | $0 | Sell |
12,091
-1,005
| -8% | – | ﹤0.01% | 940 |
|
|
2016
Q1 | $0 | Sell |
13,096
-294
| -2% | – | ﹤0.01% | 925 |
|
|
2015
Q4 | $0 | Buy |
13,390
+10,201
| +320% | – | ﹤0.01% | 826 |
|
|
2015
Q3 | $230K | Sell |
3,189
-10,491
| -77% | -$757K | 0.02% | 569 |
|
|
2015
Q2 | $0 | Sell |
13,680
-247
| -2% | – | ﹤0.01% | 723 |
|
|
2015
Q1 | $0 | Sell |
13,927
-60
| -0.4% | – | ﹤0.01% | 690 |
|
|
2014
Q4 | $0 | Buy |
+13,987
| New | – | ﹤0.01% | 633 |
|
|
2014
Q3 | – | Sell |
-14,184
| Closed | – | – | 542 |
|
|
2014
Q2 | $0 | Buy |
+14,184
| New | – | ﹤0.01% | 537 |
|
|
2013
Q4 | – | Sell |
-16,808
| Closed | -$10K | – | 468 |
|
|
2013
Q3 | $10K | Sell |
16,808
-1,543
| -8% | -$987 | ﹤0.01% | 376 |
|
|
2013
Q2 | $10K | Buy |
+18,351
| New | +$12.8K | ﹤0.01% | 333 |
|
Freedom Investment Management's SVNT Position: Q3 2017 in Review
Freedom Investment Management sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q3 2017, closing a stake of 10,026 shares.
Freedom Investment Management first reported a position in SVNT in Q2 2013 and held it in 14 quarters. The position peaked at $230K in Q3 2015. 0 funds tracked by Wall St. Rank hold SVNT as of Q3 2017.
- Freedom Investment Management reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q3 2017 after selling out during the quarter.
- Freedom Investment Management sold 10,026 SAVIENT PHARMACEUTICALS INC shares in Q3 2017.
- Freedom Investment Management first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 14 quarters.
- Freedom Investment Management's SAVIENT PHARMACEUTICALS INC position peaked at $230K in Q3 2015.
- 0 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q3 2017.
Based on Freedom Investment Management's 13F filing for Q3 2017, filed 3 Oct 2017.